Treatment of Aortic Graft Infection in the Endovascular Era

Research output: Contribution to journalReview article

Abstract

Purpose of Review: This review provides an overview of the current literature surrounding the medical and surgical treatment of aortic graft infection with particular focus on the role of endovascular aortic grafts in the changing demographics and management of these infections. Recent Findings: Definitive therapy for aortic graft infection continues to include parenteral antibiotics and surgical explantation and revascularization procedures, which are historically vast operations and sources of significant operative stress. Surgical management has evolved to include more options for infection resistant in situ conduits, attempts at partial explantations, and use of endovascular therapy to temporize the urgent sequelae of these infections, such as aortoenteric fistula. Summary: Aortic graft infection continues to be a significant and morbid complication of graft placement even with the advent of endovascular therapy, and its treatment will only increase in difficulty as a more frail population has gained access to complex aortic repair. In the future, more flexible revascularization and partial explantation options are keys, along with long-term suppressive antibiotics where appropriate.

Original languageEnglish (US)
Article number40
JournalCurrent Infectious Disease Reports
Volume19
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Transplants
Infection
Anti-Bacterial Agents
Fistula
Therapeutics
Demography
Population

Keywords

  • Aortic graft infection
  • Aortoenteric fistula
  • Endovascular infection
  • Explantation
  • In situ reconstruction
  • Stent-graft infection

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Treatment of Aortic Graft Infection in the Endovascular Era. / Sorber, Rebecca; Osgood, Michael J.; Abularrage, Christopher Joseph; Black, James Hamilton; Lum, Ying Wei.

In: Current Infectious Disease Reports, Vol. 19, No. 11, 40, 01.11.2017.

Research output: Contribution to journalReview article

@article{e6eb32afc333442ca1200f6248019bda,
title = "Treatment of Aortic Graft Infection in the Endovascular Era",
abstract = "Purpose of Review: This review provides an overview of the current literature surrounding the medical and surgical treatment of aortic graft infection with particular focus on the role of endovascular aortic grafts in the changing demographics and management of these infections. Recent Findings: Definitive therapy for aortic graft infection continues to include parenteral antibiotics and surgical explantation and revascularization procedures, which are historically vast operations and sources of significant operative stress. Surgical management has evolved to include more options for infection resistant in situ conduits, attempts at partial explantations, and use of endovascular therapy to temporize the urgent sequelae of these infections, such as aortoenteric fistula. Summary: Aortic graft infection continues to be a significant and morbid complication of graft placement even with the advent of endovascular therapy, and its treatment will only increase in difficulty as a more frail population has gained access to complex aortic repair. In the future, more flexible revascularization and partial explantation options are keys, along with long-term suppressive antibiotics where appropriate.",
keywords = "Aortic graft infection, Aortoenteric fistula, Endovascular infection, Explantation, In situ reconstruction, Stent-graft infection",
author = "Rebecca Sorber and Osgood, {Michael J.} and Abularrage, {Christopher Joseph} and Black, {James Hamilton} and Lum, {Ying Wei}",
year = "2017",
month = "11",
day = "1",
doi = "10.1007/s11908-017-0598-1",
language = "English (US)",
volume = "19",
journal = "Current Infectious Disease Reports",
issn = "1523-3847",
publisher = "Current Science, Inc.",
number = "11",

}

TY - JOUR

T1 - Treatment of Aortic Graft Infection in the Endovascular Era

AU - Sorber, Rebecca

AU - Osgood, Michael J.

AU - Abularrage, Christopher Joseph

AU - Black, James Hamilton

AU - Lum, Ying Wei

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Purpose of Review: This review provides an overview of the current literature surrounding the medical and surgical treatment of aortic graft infection with particular focus on the role of endovascular aortic grafts in the changing demographics and management of these infections. Recent Findings: Definitive therapy for aortic graft infection continues to include parenteral antibiotics and surgical explantation and revascularization procedures, which are historically vast operations and sources of significant operative stress. Surgical management has evolved to include more options for infection resistant in situ conduits, attempts at partial explantations, and use of endovascular therapy to temporize the urgent sequelae of these infections, such as aortoenteric fistula. Summary: Aortic graft infection continues to be a significant and morbid complication of graft placement even with the advent of endovascular therapy, and its treatment will only increase in difficulty as a more frail population has gained access to complex aortic repair. In the future, more flexible revascularization and partial explantation options are keys, along with long-term suppressive antibiotics where appropriate.

AB - Purpose of Review: This review provides an overview of the current literature surrounding the medical and surgical treatment of aortic graft infection with particular focus on the role of endovascular aortic grafts in the changing demographics and management of these infections. Recent Findings: Definitive therapy for aortic graft infection continues to include parenteral antibiotics and surgical explantation and revascularization procedures, which are historically vast operations and sources of significant operative stress. Surgical management has evolved to include more options for infection resistant in situ conduits, attempts at partial explantations, and use of endovascular therapy to temporize the urgent sequelae of these infections, such as aortoenteric fistula. Summary: Aortic graft infection continues to be a significant and morbid complication of graft placement even with the advent of endovascular therapy, and its treatment will only increase in difficulty as a more frail population has gained access to complex aortic repair. In the future, more flexible revascularization and partial explantation options are keys, along with long-term suppressive antibiotics where appropriate.

KW - Aortic graft infection

KW - Aortoenteric fistula

KW - Endovascular infection

KW - Explantation

KW - In situ reconstruction

KW - Stent-graft infection

UR - http://www.scopus.com/inward/record.url?scp=85029657093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029657093&partnerID=8YFLogxK

U2 - 10.1007/s11908-017-0598-1

DO - 10.1007/s11908-017-0598-1

M3 - Review article

C2 - 28929289

AN - SCOPUS:85029657093

VL - 19

JO - Current Infectious Disease Reports

JF - Current Infectious Disease Reports

SN - 1523-3847

IS - 11

M1 - 40

ER -